Exchange: NASDAQ·Updated 07:30 PM EDT
HRMY logo

HRMY Harmony Biosciences Holdings Inc

$41.00
$0.72
(1.69%)
Today
Closed $42.02
$1.02
(2.43%)
After Hours
EarningsNov 3
Mkt Cap$2.45B
Vol3.82M

About HRMY

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
53

Neutral Sentiment

How do you feel about HRMY?

Advertisement|Remove ads.